Zevra Therapeutics, Inc. ZVRA Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s other non-current liabilities?
- Zevra Therapeutics, Inc. (ZVRA) reported other non-current liabilities of $1.86M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s other non-current liabilities changed year-over-year?
- Zevra Therapeutics, Inc.'s other non-current liabilities decreased by 61.9% year-over-year, from $4.88M to $1.86M.
- What is the long-term trend for Zevra Therapeutics, Inc.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Zevra Therapeutics, Inc.'s other non-current liabilities has grown at a 63.9% compound annual growth rate (CAGR), from $145K to $1.71M.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.